search
Back to results

Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences (CO-CREATE-Ex)

Primary Purpose

COVID-19, COVID-19 Pandemic

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
COVID-19 walk-up, on-site testing strategy
Community Health Worker (CHW) leading testing navigation and general preventive care reminders
No-cost self-testing kit vending machines
Sponsored by
University of California, San Diego
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for COVID-19 focused on measuring covid-19 testing, vaccine hesitancy, implementation, vending machine

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Speak English and/or Spanish Affiliated with San Ysidro Health as a patient at select clinics (San Ysidro, Chula Vista, Lincoln Park, and Logan Heights) OR A member of a community near a San Ysidro Health clinic (San Ysidro, Chula Vista, Lincoln Park, and Logan Heights). Exclusion Criteria: Institutionalization for psychiatric disorder, developmental delay, or criminal activity. Unable to provide informed consent.

Sites / Locations

  • San Ysidro Health CentersRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Placebo Comparator

Experimental

Experimental

Experimental

Arm Label

San Ysidro Health Center - Main Clinic

San Ysidro Health Center - Logan Heights

San Ysidro Health Center - Lincoln Park

San Ysidro Health Center - Chula Vista

Arm Description

At the main clinic all 3 strategies will be available: walk-up testing, vending machine, and Community Health Worker (CHW) providing education.

A vending machine and Community Health Worker (CHW) providing education will be available at Logan Heights

A vending machine and Community Health Worker (CHW) providing education will be available at Lincoln Park

A vending machine and Community Health Worker (CHW) providing education will be available at Chula Vista

Outcomes

Primary Outcome Measures

Identify solutions and evaluation methods to refine a multi-component implementation strategy bundle using a Community and Scientific Advisory Board.
The primary objective is to refine and operationalize the multi-component implementation strategy bundle and measures of implementation and sustainment success for rapid FDA-authorized COVID-19 rapid testing using the partnership with the Global Arc and Community and Scientific Advisory Board. Each session will be recorded while Global Arc partners guide the board to identify potential failures in the implementation design. Measures of success will be collected by partner engagement surveys, which will be administered and analyzed after each meeting.

Secondary Outcome Measures

Number of distributed rapid antigen tests within our target communities as measured by a proxy outcome.
The secondary objective is to implement and evaluate the impact of our multicomponent implementation strategy bundle to optimize COVID-19 rapid testing among underserved, Latino communities. Implementation strategies include a vending machine, Community Health Workers, and walk-up testing tables. Each strategy will be rolled-out across four clinics over 18 months.

Full Information

First Posted
March 2, 2023
Last Updated
October 13, 2023
Sponsor
University of California, San Diego
Collaborators
San Ysidro Health Center
search

1. Study Identification

Unique Protocol Identification Number
NCT05894655
Brief Title
Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences
Acronym
CO-CREATE-Ex
Official Title
CO-CREATE-Ex: Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
August 28, 2023 (Actual)
Primary Completion Date
November 30, 2024 (Anticipated)
Study Completion Date
November 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, San Diego
Collaborators
San Ysidro Health Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Throughout the Coronavirus disease (COVID-19) pandemic, rates of COVID-19 have been persistently high in San Diego County's central and southern communities near the United States/Mexico border. These regions predominantly house Latino residents, the ethnic minority community most impacted by COVID-19 in San Diego. In the Phase I project, University of California, San Diego (UCSD) partnered with San Ysidro Health (SYH) and the Global Action Research Center, to co-create and demonstrate the impact of a COVID-19 testing program in San Ysidro, one of the most impacted areas from COVID-19 in San Diego County. To date, the project tested >10,000 community members (92% Latino) and received requests to scale-out the testing program to additional primary care clinic sites. In this Phase III project, Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences (CO-CREATE-Ex) will extend work with the Phase I community and clinical partners to refine, specify, implement, and evaluate an implementation strategy bundle that optimizes COVID-19 testing, expanding beyond current polymerase chain reaction (PCR) testing to FDA-authorized COVID-19 rapid antigen testing.
Detailed Description
CO-CREATE-Ex will roll-out our implementation using 3 strategies: keeping the current, walk-up free testing protocol Offering Community Health Worker (CHW) to lead COVID-19 test counseling, preventive care reminders, and offer testing support Installing vending machines that will dispense FDA-authorized self-testing kits. For each strategy, participants will consent into study, provide demographics and test history, and receive a free rapid antigen test (RAT) kit. After receiving the test kit, participants will be prompted to return their results and fill out a survey about their COVID-19 experiences. Study subjects will be contacted up to three times over a course of 4 weeks to return their results and complete the survey. Study coordinators will use participants' preferred method of contact.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
COVID-19, COVID-19 Pandemic
Keywords
covid-19 testing, vaccine hesitancy, implementation, vending machine

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Model Description
The investigators chose a roll-out implementation optimization (ROIO) design to implement the study. This is a novel implementation science study design that affords a balance of rigor and flexibility to rapidly and iteratively refine in response to dynamic contexts like the pandemic.
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
7500 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
San Ysidro Health Center - Main Clinic
Arm Type
Placebo Comparator
Arm Description
At the main clinic all 3 strategies will be available: walk-up testing, vending machine, and Community Health Worker (CHW) providing education.
Arm Title
San Ysidro Health Center - Logan Heights
Arm Type
Experimental
Arm Description
A vending machine and Community Health Worker (CHW) providing education will be available at Logan Heights
Arm Title
San Ysidro Health Center - Lincoln Park
Arm Type
Experimental
Arm Description
A vending machine and Community Health Worker (CHW) providing education will be available at Lincoln Park
Arm Title
San Ysidro Health Center - Chula Vista
Arm Type
Experimental
Arm Description
A vending machine and Community Health Worker (CHW) providing education will be available at Chula Vista
Intervention Type
Behavioral
Intervention Name(s)
COVID-19 walk-up, on-site testing strategy
Intervention Description
This strategy is a no-appointment, walk-up point-of-care PCR and rapid testing strategy for clinic patients and community members. It will be offered 5 days/week for 7 hours during the first 3 months of the trial at Clinic 1. The intensity will decrease over the trial ending with 1 SYH Medical Assistant overseeing the testing protocol. Bilingual research staff will be trained to oversee onsite testing.
Intervention Type
Behavioral
Intervention Name(s)
Community Health Worker (CHW) leading testing navigation and general preventive care reminders
Intervention Description
This strategy provides health counseling about when COVID-19 testing is recommended, which test to use, testing instructions, and how to interpret results. Community Health Workers (CHW) will also offer general preventive health care reminders such as flu shots, blood pressure checks, and A1c screenings. This strategy will be available full-time during the first 3 months of roll-out at each clinic and after 3 months, the CHW will be available as needed. Trained bilingual CHW will be supervised by a SYH employee.
Intervention Type
Behavioral
Intervention Name(s)
No-cost self-testing kit vending machines
Intervention Description
This strategy includes vending machines that will provide interactive instructions for accessing free self-testing COVID-19 kits located outside of clinics for patients and community members to use anytime. The vending machines will be available 24 hours/day, 7 days a week.
Primary Outcome Measure Information:
Title
Identify solutions and evaluation methods to refine a multi-component implementation strategy bundle using a Community and Scientific Advisory Board.
Description
The primary objective is to refine and operationalize the multi-component implementation strategy bundle and measures of implementation and sustainment success for rapid FDA-authorized COVID-19 rapid testing using the partnership with the Global Arc and Community and Scientific Advisory Board. Each session will be recorded while Global Arc partners guide the board to identify potential failures in the implementation design. Measures of success will be collected by partner engagement surveys, which will be administered and analyzed after each meeting.
Time Frame
2 years
Secondary Outcome Measure Information:
Title
Number of distributed rapid antigen tests within our target communities as measured by a proxy outcome.
Description
The secondary objective is to implement and evaluate the impact of our multicomponent implementation strategy bundle to optimize COVID-19 rapid testing among underserved, Latino communities. Implementation strategies include a vending machine, Community Health Workers, and walk-up testing tables. Each strategy will be rolled-out across four clinics over 18 months.
Time Frame
18 months

10. Eligibility

Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Speak English and/or Spanish Affiliated with San Ysidro Health as a patient at select clinics (San Ysidro, Chula Vista, Lincoln Park, and Logan Heights) OR A member of a community near a San Ysidro Health clinic (San Ysidro, Chula Vista, Lincoln Park, and Logan Heights). Exclusion Criteria: Institutionalization for psychiatric disorder, developmental delay, or criminal activity. Unable to provide informed consent.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Breanna Reyes, MPH
Phone
858-945-4553
Email
cocreate@health.ucsd.edu
First Name & Middle Initial & Last Name or Official Title & Degree
CO-CREATE-EX Project
Phone
858-945-4554
Email
cocreate@health.ucsd.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Louise Laurent, MD/PhD
Organizational Affiliation
University of California, San Diego
Official's Role
Principal Investigator
Facility Information:
Facility Name
San Ysidro Health Centers
City
San Ysidro
State/Province
California
ZIP/Postal Code
92173
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Breanna Reyes, MPH
First Name & Middle Initial & Last Name & Degree
Louise Laurent, MD/PhD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences

We'll reach out to this number within 24 hrs